Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Mallon

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
JNCI Cancer Spectrum|July 31, 2019
Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast CancerQiong Gao, Elena López-Knowles, Maggie Chon U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM TrialJohn M S Bartlett, Keying Xu, Jenna Wong, et al.
Breast Cancer Research and Treatment|February 5, 2026
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudyAndréanne Leblanc, Ana-Alicia Beltran-Bless, Gregory R Pond, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Breast (Edinburgh, Scotland)|July 9, 2025
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?Ana-Alicia Beltran-Bless, Gregory R Pond, Jane Bayani, et al.
Breast Cancer Research : BCR|July 2, 2025
Cancer-associated fibroblast driven paracrine IL-6/STAT3 signaling promotes migration and dissemination in invasive lobular carcinomaEsme Bullock, Aleksandra Rozyczko, Sana Shabbir, et al.
Journal of Medical Internet Research|April 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation StudyLisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless, et al.
Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
JNCI Cancer Spectrum|July 31, 2019
Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast CancerQiong Gao, Elena López-Knowles, Maggie Chon U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM TrialJohn M S Bartlett, Keying Xu, Jenna Wong, et al.
Breast Cancer Research and Treatment|February 5, 2026
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudyAndréanne Leblanc, Ana-Alicia Beltran-Bless, Gregory R Pond, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Breast (Edinburgh, Scotland)|July 9, 2025
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?Ana-Alicia Beltran-Bless, Gregory R Pond, Jane Bayani, et al.
Breast Cancer Research : BCR|July 2, 2025
Cancer-associated fibroblast driven paracrine IL-6/STAT3 signaling promotes migration and dissemination in invasive lobular carcinomaEsme Bullock, Aleksandra Rozyczko, Sana Shabbir, et al.
Journal of Medical Internet Research|April 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation StudyLisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless, et al.
Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.
Pageof 4